Disc Medicine, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Disc Medicine, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Disc Medicine, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $15.9M, a 79.4% decline year-over-year.
  • Disc Medicine, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $239M, a 60.7% increase from 2022.
  • Disc Medicine, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $149M, a 65.7% increase from 2021.
  • Disc Medicine, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $89.9M, a 163% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15.9M -$61.4M -79.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $77.3M +$77.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $55K* -$195M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $195M +$175M +873% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 $122M Jun 25, 2020 Sep 30, 2020 10-Q 2020-11-12
Q1 2020 $20.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.